ArticleCellular and molecular life sciences : CMLS2026
RNA binding protein Sam68 promotes germinal center reaction and IgG response through regulation of miR29.
Article in Cellular and molecular life sciences : CMLS, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The RNA binding protein Sam68 (Src associated during mitosis of 68 kDa) has recently been shown to be involved in DNA double strand break repair. In the course of development and immune response, B cells undergo physiological double strand breaks during V(D)J recombination and class switch recombination. Therefore, envisaging a crucial role of Sam68 in B cell development and function, we analyzed Sam68 complete knockout (KO) mice. Despite normal B cell development, these animals exhibit impaired germinal centre (GC) reactions and antibody responses. Using a competitive bone marrow chimera model, as well as adoptive B cell transfer model, we could demonstrate that Sam68 deficient B cells are less competent to participate in GC than WT B cells. This reduced competence is mainly attributed to impaired B cell-intrinsic CD40 signaling as Sam68 KO B cells are less responsive to CD40 stimulation in vitro. Sam68 deficient B cells up-regulate the expression of microRNA miR29a and b which in turn repress the expression of Tumor necrosis factor receptor-associated factor 4 (Traf4) gene, a downstream effector molecule of CD40 pathway. Thus, Sam68 mediated Traf4 regulation through miR29 plays an important role in CD40 signaling in B cells, hence in GC response.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.